Torras J - Search Results

1

Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.

Waldman M, Soler MJ, García-Carro C, Lightstone L, Turner-Stokes T, Griffith M, Torras J, Valenzuela LM, Bestard O, Geddes C, Flossmann O, Budge KL, Cantarelli C, Fiaccadori E, Delsante M, Morales E, Gutierrez E, Niño-Cruz JA, Martinez-Rueda AJ, Comai G, Bini C, La Manna G, Slon MF, Manrique J, Agraz I, Sinaii N, Cravedi P. Waldman M, et al. Among authors: torras j. Kidney Int. 2021 Jan;99(1):227-237. doi: 10.1016/j.kint.2020.10.032. Epub 2020 Nov 9. Kidney Int. 2021. PMID: 33181156 Free PMC article.

2

Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results.

Rama I, Cruzado JM, Gil-Vernet S, Torras J, Serón D, Castelao AM, Ibernón M, Bestard O, Grinyó JM. Rama I, et al. Among authors: torras j. Transplantation. 2005 Jul 27;80(2):164-8. doi: 10.1097/01.tp.0000165109.06382.56. Transplantation. 2005. PMID: 16041259

3

Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.

Bestard O, Cruzado JM, Ercilla G, Gomà M, Torras J, Serón D, Rama I, Ibernon M, Viñas O, Carrera M, Grinyó JM. Bestard O, et al. Among authors: torras j. Nephrol Dial Transplant. 2006 Aug;21(8):2320-4. doi: 10.1093/ndt/gfl266. Epub 2006 Jun 4. Nephrol Dial Transplant. 2006. PMID: 16751656 No abstract available.

4

Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.

Bestard O, Cruzado JM, Mestre M, Caldés A, Bas J, Carrera M, Torras J, Rama I, Moreso F, Serón D, Grinyó JM. Bestard O, et al. Among authors: torras j. J Immunol. 2007 Oct 1;179(7):4901-9. doi: 10.4049/jimmunol.179.7.4901. J Immunol. 2007. PMID: 17878390

5

Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts.

Bestard O, Cruzado JM, Rama I, Torras J, Gomà M, Serón D, Moreso F, Gil-Vernet S, Grinyó JM. Bestard O, et al. Among authors: torras j. J Am Soc Nephrol. 2008 Oct;19(10):2020-6. doi: 10.1681/ASN.2007111174. Epub 2008 May 21. J Am Soc Nephrol. 2008. PMID: 18495961 Free PMC article.

6

Optimal immunosuppression to prevent chronic allograft dysfunction.

Grinyó JM, Bestard O, Torras J, Cruzado JM. Grinyó JM, et al. Among authors: torras j. Kidney Int Suppl. 2010 Dec;(119):S66-70. doi: 10.1038/ki.2010.426. Kidney Int Suppl. 2010. PMID: 21116321 Free article. Review.

7

Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation.

Bestard O, Cassis L, Cruzado JM, Torras J, Franquesa M, Gil-Vernet S, Lucia M, Grinyó JM. Bestard O, et al. Among authors: torras j. Transpl Int. 2011 May;24(5):451-60. doi: 10.1111/j.1432-2277.2011.01223.x. Epub 2011 Feb 5. Transpl Int. 2011. PMID: 21294788 Free article. Clinical Trial.

8

Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.

Cruzado JM, Poveda R, Ibernón M, Díaz M, Fulladosa X, Carrera M, Torras J, Bestard O, Navarro I, Ballarín J, Romero R, Grinyó JM. Cruzado JM, et al. Among authors: torras j. Nephrol Dial Transplant. 2011 Nov;26(11):3596-602. doi: 10.1093/ndt/gfr072. Epub 2011 Mar 10. Nephrol Dial Transplant. 2011. PMID: 21393611 Clinical Trial.

9

Immunosuppression in the era of biological agents.

Grinyó JM, Cruzado JM, Bestard O, Vidal Castiñeira JR, Torras J. Grinyó JM, et al. Among authors: torras j. Adv Exp Med Biol. 2012;741:60-72. doi: 10.1007/978-1-4614-2098-9_5. Adv Exp Med Biol. 2012. PMID: 22457103

10

Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell function.

Llaudó I, Cassis L, Torras J, Bestard O, Franquesa Ml, Cruzado JM, Cerezo G, Castaño E, Pétriz J, Herrero-Fresneda I, Grinyó JM, Lloberas N. Llaudó I, et al. Among authors: torras j. J Pharm Pharm Sci. 2012;15(3):407-19. doi: 10.18433/j3g30b. J Pharm Pharm Sci. 2012. PMID: 22974789 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page